MAPT and Alzheimer disease: The observed range of estimated regional annualized rates of tau accumulation relative to cognitively unimpaired was comparable to the findings of another recent longitudinal study on typical AD patients, where tau deposition was measured as [18F]AV-1451 PET uptake (Jack et al., 2018).